title: Most 70- to 79-year-old patients with acute myeloid leukemia do benefit from intensive treatment.
authors: Gunnar
authors: G
authors: Juliusson
mesh_terms: D000368:Aged; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D015331:Cohort Studies; D015897:Comorbidity; D003422:Critical Care / Q000379:methods*; D003561:Cytarabine / Q000008:administration & dosage; D003657:Decision Making; D006801:Humans; D015470:Leukemia, Myeloid, Acute / Q000188:drug therapy* / Q000453:epidemiology / Q000401:mortality; D018570:Risk Assessment; D016019:Survival Analysis; D013548:Sweden / Q000453:epidemiology; D016896:Treatment Outcome; D054928:Validation Studies as Topic
chemical_list: D003561:Cytarabine